Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (Unaudited)

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

The following table represents certain unaudited quarterly information for the eight quarters ended December 31, 2017. This data has been derived from unaudited consolidated financial statements that, in the opinion of the Company’s management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of such information when read in conjunction with the Company’s annual audited consolidated financial statements and notes thereto appearing elsewhere in this report. These operating results are not necessarily indicative of results for any future period (in thousands, except per share data):

	Year Ended December 31, 2017
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Total net revenues	$	—		$	2		$	1		$	568		(1)
Gross profit(2)	—			—			—			551
Net loss	(16,028		)	(20,745		)	(23,360		)	(29,357		)
Net loss per share, basic and diluted	(0.72		)	(0.93		)	(1.04		)	(1.27		)

	Year Ended December 31, 2016
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Total net revenues	$	175		$	222		$	138		$	37
Gross profit	—			—			—			—
Net loss	(13,828		)	(16,876		)	(14,394		)	(14,960		)
Net loss per share, basic and diluted	(0.65		)	(0.78		)	(0.66		)	(0.68		)

(1) In the fourth quarter of 2017 the Company commenced commercial sales of GOCOVRI.

(2) Gross profit is computed by subtracting cost of product sales from product sales, net.